title: Poor results for everolimus in patients with liver cancer.
authors.forename: Talha Khan
authors.initials: TK
authors.lastname: Burki
mesh_terms: D005260:Female; D006801:Humans; D008297:Male; D000970:Antineoplastic Agents / Q000627:therapeutic use; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy / Q000401:mortality / Q000473:pathology; D000068338:Everolimus; D008113:Liver Neoplasms / Q000188:drug therapy / Q000401:mortality / Q000473:pathology; D009536:Niacinamide / Q000031:analogs & derivatives / Q000627:therapeutic use; D010671:Phenylurea Compounds / Q000627:therapeutic use; D011379:Prognosis; D018570:Risk Assessment; D020123:Sirolimus / Q000031:analogs & derivatives / Q000627:therapeutic use; D000077157:Sorafenib; D016019:Survival Analysis; D017211:Treatment Failure
chemical_list: D000970:Antineoplastic Agents; D000068338:Everolimus; D009536:Niacinamide; D010671:Phenylurea Compounds; D020123:Sirolimus; D000077157:Sorafenib